Skip to main content
Joe S. Mendez
( out of 125 reviews )

Joe S. Mendez, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Neuro-Oncology
Salt Lake City
801-585-0250
  • Video Player is loading.
    Current Time 0:00
    Duration -:-
    Loaded: 0%
    Stream Type LIVE
    Remaining Time -:-
     
    1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Joe Mendez, MD is an Assistant Professor in the Department of Neurosurgery at the University of Utah and an Investigator at the Huntsman Cancer Institute. He specializes in Neuro-Oncology with a focus on treating patients with gliomas, primary central nervous system lymphoma (PCNSL), and metastatic disease to the central nervous system.

      Dr. Mendez received his bachelor’s degree in Environmental Engineering and Science from Rice University followed by his medical degree from the University of California, San Francisco. He completed his neurology residency at Washington University in St. Louis/Barnes-Jewish Hospital where he also served as Chief Resident. He most recently completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center in New York City.

      Dr. Mendez’s research interests include clinical trial research focused on the treatment of gliomas and primary central nervous system lymphoma. His other interest is medical education with a focus on teaching and mentoring medical students, residents, and fellows.

      Dr. Mendez is originally from Wichita Falls, Texas. He enjoys playing tennis and traveling to international destinations with his partner, who is a Radiologist in the Breast Imaging Division at the University of Utah.

      Board Certification

      American Board of Psychiatry & Neurology (Neurology)
      United Council for Neurologic Subspecialties (Neuro-oncology)

      Patient Rating

      4.9 /5
      ( out of 125 reviews )

      The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

      The scale on which responses are measured is 1 to 5 with 5 being the best score.

      Patient Comments

      Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

      June 20, 2025
      HUNTSMAN CANCER CENTER

      Dr. Mendez is outstanding and so kind and helpful.

      May 29, 2025
      HUNTSMAN CANCER CENTER

      He answers my questions in a way I can understand my issues.

      May 19, 2025
      HUNTSMAN CANCER CENTER

      Doctor Mendez is just the best. He's kind, caring, and friendly. Most importantly he saved my life. I can't be more thankful to him and for him.

      May 16, 2025
      HUNTSMAN CANCER CENTER

      Dr. Mendez is very knowledgeable, caring and kind

      April 20, 2025
      HUNTSMAN CANCER CENTER

      Dr. Mendez is very bright and intelligent. He informs patient and family and keeps them updated.

      April 14, 2025
      HUNTSMAN CANCER CENTER

      Dr. Mendez is very helpful and open but also to the point of diagnosis. Answers questions that we have if we have any that are pressing. He is willing to work with us out of state with other providers so we can receive local treatment.

      April 07, 2025
      HUNTSMAN CANCER CENTER

      Dr Mendez is the best. God bless him to continue grow his knowledge to help others. Dr Mendez is very kind and listen to my concerns

      April 06, 2025
      HUNTSMAN CANCER CENTER

      Dr Mendez is so awesome. He is always super informative about the treatment process and now about our maintenance follow-ups. He is always pleased to see us and never seems rushed (we know his schedule is very full), we are truly blessed that he is our physician.

      April 02, 2025
      HUNTSMAN CANCER CENTER

      Dr Mendez is an excellent doctor and I consider him a well experienced expert in his field of medicine. I particularly appreciate his excellent communication and investigating all options best for me. Dr Mendez discuses all the options with me patiently answering all my questions. I know I have the received the best of health care with Dr Mendez and have been blessed with a positive outcome.

    • Joe Mendez, MD is an Assistant Professor in the Department of Neurosurgery at the University of Utah and an Investigator at the Huntsman Cancer Institute. He specializes in Neuro-Oncology with a focus on treating patients with gliomas, primary central nervous system lymphoma (PCNSL), and metastatic disease to the central nervous system.

      Dr. Mendez received his bachelor’s degree in Environmental Engineering and Science from Rice University followed by his medical degree from the University of California, San Francisco. He completed his neurology residency at Washington University in St. Louis/Barnes-Jewish Hospital where he also served as Chief Resident. He most recently completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center in New York City.

      Dr. Mendez’s research interests include clinical trial research focused on the treatment of gliomas and primary central nervous system lymphoma. His other interest is medical education with a focus on teaching and mentoring medical students, residents, and fellows.

      Dr. Mendez is originally from Wichita Falls, Texas. He enjoys playing tennis and traveling to international destinations with his partner, who is a Radiologist in the Breast Imaging Division at the University of Utah.

      Board Certification and Academic Information

      Academic Departments Neurosurgery -Assistant Professor (Clinical)
      Neurology -Adjunct Assistant Professor
      Board Certification
      American Board of Psychiatry & Neurology (Neurology)
      United Council for Neurologic Subspecialties (Neuro-oncology)

      Education history

      Fellowship Neuro-Oncology - Memorial Sloan Kettering Cancer Center Fellow
      Chief Resident Neurology - Washington University School of Medicine in St. Louis Administrative Chief Resident
      Residency Neurology - Washington University School of Medicine in St. Louis/Barnes-Jewish Hospital Resident
      Internship Internal Medicine - Washington University School of Medicine in St. Louis/Barnes-Jewish Hospital Intern
      Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
      Undergraduate Environmental Engineering and Science - Rice University B.A.

      Selected Publications

      Journal Article

      1. Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H (2024). Phase 1b/2 Study of Orally Administered Pexidartinib in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma. Neuro-Oncology Advances, 6(1), vdae202.
      2. Robinson LJ, Goold E, Cannon DM, Mendez JS, Menacho ST, Mao Q, Liu T (2024). A rare case of an adult primary intracranial sarcoma associated with a DICER1 mutation. J Neuropathol Exp Neurol, 83(5), 365-369. (Read full article)
      3. Arnold L, Hoshina Y, Hyejung L, Haaland B, Colman H, Mendez JS (2024). Effect of Pneumocystis jirovecii Pneumonia Prophylaxis on Hematologic Toxicity in Patients Receiving Chemoradiation for Primary BrainTumors. J Neurooncol, 167(1), 211-217.
      4. Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF (2023). Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. N Engl J Med, 389(7), 589-601. (Read full article)
      5. Earl ER, Colman H, Mendez J, Jensen RL, Karsy M (2023). An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah. Neurooncol Pract, 10(5), 472-481. (Read full article)
      6. Lucas CG, Davidson CJ, Alashari M, Putnam AR, Whipple NS, Bruggers CS, Mendez JS, Cheshier SH, Walker JB, Ramani B, Cadwell CR, Sullivan DV, Lu R, Mirchia K, Van Ziffle J, Devine P, Goldschmidt E, Hervey-Jumper SL, Gupta N, Oberheim Bush NA, Raleigh DR, Bollen A, Tihan T, Pekmezci M, Solomon DA, Phillips JJ, Perry A (2023). Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma. J Neuropathol Exp Neurol, 81(8), 650-657. (Read full article)
      7. Gelhard S, Maxwell A, Colman H, Cohen AL, Mendez JS (2022). Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis. J Neurooncol, 159(2), 293-300. (Read full article)
      8. Kraus RD, Weil CR, Su FCF, Cannon DM, Burt LM, Mendez JS (2022). Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients. Neurooncol Pract, 9(5), 380-389. (Read full article)
      9. Guney E, Lucas CG, Qi Z, Yu J, Zhang R, Ohgami RS, Rubenstein JL, Bou DR, Schafernak KT, Wertheim GB, Dahiya S, Giulino-Roth L, Attarbaschi A, Barth MJ, Kothari S, Abla O, Cohen AL, Mendez JS, Bollen AW, Perry A, Tihan T, Pekmezci M, Solomon DA, Wen KW (2022). A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome. Blood Adv, 6, 3189-3193. (Read full article)
      10. Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt LM (2020). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. J Neurooncol, 151(2), 93-101. (Read full article)
      11. Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C (2018). The elderly left behind – Changes in survival trends of primary central nervous system lymphoma over the past four decades. Neuro Oncol, 20(5), 687-694.
      12. Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW (2015). Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg, 123(2), 373-86. (Read full article)

      Review

      1. Kropp S, Mendez JS (2024). Advancements in Targeted Molecular Therapy for Low-Grade Gliomas: Challenging the Treatment Paradigm. [Review]. Practical Neurology, 23(3), 56-59.
      2. Azab MA, Cole K, Earl E, Cutler C, Mendez J, Karsy M (2023). Medical Management of Meningiomas. [Review]. Neurosurg Clin N Am, 34(3), 319-333. (Read full article)